Cedars-Sinai is working to understanding how the immune system of cancer patients responds to COVID-19 vaccinations to address the pandemic and can help prepare for the next.
Wei Gao, PhD and research team at Cedars-Sinai have designed an MRI-compatible crib to better study infants’ brains. He explains why this research is key to understanding early childhood development.
A rare disorder that disrupts the motion skills of infants and teenagers has been discovered thanks to a research collaboration involving a Cedars-Sinai pediatric neurologist. Dr. Tyler Pierson, PhD, joined with fellow scientists from nearly 50 institutions worldwide to report on 31 children with the condition, dubbed “HPDL deficiency.”
The mechanisms behind idiopathic pulmonary fibrosis (IPF), a dangerous disease that scars the lungs and impairs breathing, are being demystified by Cedars-Sinai investigators.
COVID-19 altered the landscape of medicine. Today, Cedars-Sinai providers share how they rose to meet challenges and their lasting lessons that could be applied to the next pandemic.
Dramatic advances in the field of minimally invasive heart valve replacement are extending and improving life for millions. Cedars-Sinai physicians are seeking the next frontier.
Public health efforts and scientific advances have led to a significant drop in lung cancer deaths, but researchers are still searching for cures for the No. 1 cancer scourge.
Cedars-Sinai Cancer has joined with precision medicine firm Tempus to design cancer treatment options that are increasingly personalized. The partnership harnesses artificial intelligence and big data to create virtual replicas of patients' DNA, RNA, protein and other information to help identify the most effective approach to overcoming each individual’s disease.